Paroxetine-induced Hypoglycemia in Type 2 Diabetic Patient.
10.12771/emj.2016.39.1.14
- Author:
Seunghee HAN
1
;
Hye Sun PARK
;
Yong Ho LEE
;
Byung Wan LEE
;
Eun Seok KANG
;
Bong Soo CHA
Author Information
1. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. bscha@yuhs.ac
- Publication Type:Case Report
- Keywords:
Serotonin uptake inhibitor;
Paroxetine;
hypoglycemia;
Type 2 diabetes mellitus
- MeSH:
Adult;
Depression;
Diabetes Mellitus, Type 2;
Diabetic Nephropathies;
Female;
Humans;
Hypoglycemia*;
Insulin;
Paroxetine;
Serotonin Uptake Inhibitors
- From:The Ewha Medical Journal
2016;39(1):14-16
- CountryRepublic of Korea
- Language:English
-
Abstract:
Selective serotonin reuptake inhibitors are commonly prescribed drugs for the treatment of depression in the patients with diabetes. Here, we report a case of paroxetineinduced severe recurrent hypoglycemia that developed in a 35-year-old woman with poorly controlled type 2 diabetes complicated by diabetic nephropathy and neuropathy. She discontinued her daily insulin therapy 2 months after the introduction of paroxetine, but hypoglycemic events were sustained. After discontinuation of paroxetine, no more hypoglycemic events occurred.
